tiprankstipranks
Trending News
More News >
DANONE SA (FR:BN)
:BN
Advertisement

DANONE SA (BN) AI Stock Analysis

Compare
54 Followers

Top Page

FR

DANONE SA

(LSE:BN)

Rating:61Neutral
Price Target:
€74.00
▲(9.34%Upside)
Danone SA's strong financial performance, marked by improved profitability and reduced leverage, is a positive factor. However, bearish technical indicators and a fair valuation limit the stock's attractiveness. The absence of earnings call data and corporate events means these are not factors in this evaluation.
Positive Factors
Market Position
Danone Aptamil holds a significant market share at 14% in the China IMF market.
Product Innovation
The all-important EDP turnaround in Europe looks underway, well-underpinned by product launches which we find reassuring for the margin story.
Sales Growth
The implied sales growth of over 10% is very positive for the outlook on demand.
Negative Factors
Competition
The coffee creamers category in the US, which is significant for the group, faces increasing competition.
Margin Pressure
Feihe's launch of a maternity subsidy program suggests potential margin risks for competitors in China.
Profit Warning
A Feihe profit warning may weigh on Danone, with Feihe shares down 17%.

DANONE SA (BN) vs. iShares MSCI France ETF (EWQ)

DANONE SA Business Overview & Revenue Model

Company DescriptionDanone S.A. is a multinational food-products corporation headquartered in Paris, France. The company operates in three primary sectors: Essential Dairy and Plant-Based Products, Waters, and Specialized Nutrition. Danone is renowned for its diverse range of products including yogurts, plant-based foods and beverages, bottled water, infant nutrition, and medical nutrition products. With a commitment to health and sustainability, Danone aims to offer nutritious and sustainable food options to consumers around the globe.
How the Company Makes MoneyDanone makes money through its diversified portfolio of health-focused food and beverage products. The company's revenue model is primarily based on the sale of its products in the Essential Dairy and Plant-Based Products, Waters, and Specialized Nutrition segments. The Essential Dairy and Plant-Based Products division generates income through the sale of yogurt, dairy desserts, and plant-based alternatives. The Waters segment contributes to revenue through the sale of bottled water brands like Evian and Volvic. The Specialized Nutrition segment includes the sale of infant formula and medical nutrition products. Additionally, Danone's earnings are supported by strategic partnerships with retailers and distributors worldwide, as well as its investment in research and development for product innovation and sustainability initiatives.

DANONE SA Financial Statement Overview

Summary
Danone SA shows a stable gross profit margin and improved net profit margin, indicating enhanced profitability. The balance sheet reflects strong equity and reduced debt, showcasing prudent financial management. Robust cash flow generation supports strategic initiatives, although revenue growth remains a challenge.
Income Statement
75
Positive
Danone SA shows a stable gross profit margin with a consistent EBIT and EBITDA margin over the years. The net profit margin improved significantly in 2024 compared to 2023, indicating enhanced profitability. However, revenue growth has been stagnant, reflecting competitive industry pressures.
Balance Sheet
80
Positive
The company's balance sheet reflects strong equity figures, with a notable reduction in total debt by 2024, resulting in a debt-to-equity ratio of 0. This indicates prudent financial management and reduced leverage risk. The equity ratio has remained stable, showcasing a solid financial foundation.
Cash Flow
78
Positive
Danone demonstrates robust free cash flow generation with positive growth in free cash flow from 2023 to 2024. The operating cash flow to net income ratio indicates efficient cash generation relative to earnings. However, fluctuations in investing and financing cash flows suggest potential volatility in capital allocation strategies.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue27.38B27.62B27.66B24.28B23.62B
Gross Profit13.61B13.08B12.74B11.52B11.35B
EBITDA4.77B3.81B4.00B3.58B4.30B
Net Income2.02B881.00M959.00M1.92B1.96B
Balance Sheet
Total Assets45.29B44.49B45.28B45.42B42.78B
Cash, Cash Equivalents and Short-Term Investments6.16B6.00B4.68B5.86B4.27B
Total Debt14.80B15.60B14.16B16.59B16.50B
Total Liabilities27.44B28.26B27.29B28.05B26.48B
Stockholders Equity17.80B16.18B17.92B17.27B16.20B
Cash Flow
Free Cash Flow2.91B2.60B2.09B2.43B2.00B
Operating Cash Flow3.83B3.44B2.96B3.47B2.97B
Investing Cash Flow-463.00M-834.00M-749.00M561.00M-610.00M
Financing Cash Flow-3.82B-1.94B-1.93B-4.03B-2.27B

DANONE SA Technical Analysis

Technical Analysis Sentiment
Negative
Last Price67.68
Price Trends
50DMA
71.99
Negative
100DMA
71.07
Negative
200DMA
67.34
Positive
Market Momentum
MACD
-1.24
Negative
RSI
31.01
Neutral
STOCH
17.44
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:BN, the sentiment is Negative. The current price of 67.68 is below the 20-day moving average (MA) of 69.07, below the 50-day MA of 71.99, and above the 200-day MA of 67.34, indicating a neutral trend. The MACD of -1.24 indicates Negative momentum. The RSI at 31.01 is Neutral, neither overbought nor oversold. The STOCH value of 17.44 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:BN.

DANONE SA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
€3.35B13.7511.02%1.89%2.02%-20.95%
71
Outperform
€905.19M8.286.45%2.42%5.14%11.66%
68
Neutral
¥196.41B21.358.29%2.30%4.93%0.78%
FRBN
61
Neutral
€43.56B21.5711.87%3.18%-0.88%129.97%
FRBON
48
Neutral
€262.72M-15.69%2.45%-4.12%-13922.22%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:BN
DANONE SA
67.68
10.82
19.02%
FR:SAVE
Savencia
66.20
17.08
34.77%
FR:LOUP
Societe LDC Societe Anonyme
93.10
22.69
32.23%
FR:BON
Bonduelle
8.29
2.30
38.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 26, 2025